Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1278824 Title: CLAIRANCE PAR REOVIRUS DES CELLULES NEOPLASIQUES A MEDIATION DES RAS ISSUES DE COMPOSITIONS CELLULAIRES MIXTES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
019312511
WO application number:
CA2001000620
Type:
European patent granted for BE
Status:
Publication number:
1278824
WO publication number:
WO 2001/083711
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
02/05/2001
Grant date:
14/07/2010
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
EP B1 publication date:
14/07/2010
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):

Applicant

Name:
Oncolytics Biotech Inc.
Legal Form:
From:
14/07/2010
Address:
Suite 210 1167 Kensington Crescent N. W. Calgary AB T2N 1X7(CA), CA
To:

Priority

1

Priority patent number:
201990 P
Priority date:
03/05/2000
Priority country:
United States (US)

2

Priority patent number:
205389 P
Priority date:
19/05/2000
Priority country:
United States (US)

3

Priority patent number:
268054 P
Priority date:
13/02/2001
Priority country:
United States (US)

Classification

IPC or IDT classification:
C12N 5/078 ; A01N 1/02 ; A61L 2/00 ; A61K 35/12 ; A61K 39/42;

Additional information section

Status:
ZONDER GEVOLG / SANS EFFET
Case kind / Max duration / Publication code:
Basic patent details (Patent law 1854):
Representative details:
Inventor(s) details:
MORRIS, Donald;THOMPSON, Bradley, G.;COFFEY, Matthew, C.;
History of owners:
Filing date Document type Publication Type Document Description Number of pages File Type